DRIXINE NO DRIP FORMULA ORIGINAL PUMP MIST NASAL SPRAY oxymetazoline hydrochloride 500 ug/mL pump actuated metered dose aerosol

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

oxymetazoline hydrochloride, Quantity: 0.5 mg/mL

Commercializzato da:

Bayer Australia Ltd

INN (Nome Internazionale):

oxymetazoline hydrochloride

Forma farmaceutica:

Spray, nasal

Composizione:

Excipient Ingredients: disodium edetate; dibasic sodium phosphate; benzalkonium chloride; povidone; dispersible cellulose; monobasic sodium phosphate monohydrate; purified water; macrogol 1450; benzyl alcohol; Flavour

Via di somministrazione:

Nasal

Confezione:

15mL

Tipo di ricetta:

(S2) Pharmacy Medicine

Indicazioni terapeutiche:

Symptomatic relief of nasal and nasopharyngeal congestion associated with the common cold, flu, hayfever and sinusitis, and to facilitate visual intranasal examination. By decreasing congestion around the eustachian tube ostia, Drixine Nasal may be useful in the adjunctive treatment of congestion associated with middle ear conditions.

Dettagli prodotto:

Visual Identification: White to off-white, thick, gel-like suspension; Container Type: Bottle; Container Material: HDPE; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Stato dell'autorizzazione:

Registered

Data dell'autorizzazione:

2009-11-16